Related Experiment Video
Updated: Jan 11, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Congenital Heart Block
Erick Jimenez1, Matthew Ambrose1, Bradley Clark1
1Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota - Masonic Children's Hospital, 2450 Riverside Avenue S, Minneapolis, MN 55454, USA.
Insights
Congenital heart block (CHB) is a rare fetal condition affecting the heart's electrical system. Early diagnosis and multidisciplinary care, including new therapies, improve outcomes for affected pregnancies and neonates.
Area of Science:
- Cardiology
- Maternal-Fetal Medicine
- Pediatric Electrophysiology
Background:
- Congenital heart block (CHB) is a rare fetal arrhythmia caused by conduction system disruptions.
- Often associated with maternal autoantibodies (e.g., anti-Ro/SSA, anti-La/SSB) or congenital heart defects.
- Leads to significant fetal morbidity and mortality if untreated.
Purpose of the Study:
- To provide a comprehensive overview of congenital heart block (CHB).
- To examine current diagnostic strategies and emerging therapeutic interventions.
- To highlight the importance of multidisciplinary management for improved fetal and neonatal outcomes.
Main Methods:
- Review of current literature on CHB pathophysiology, diagnosis, and management.
- Emphasis on advances in fetal echocardiography for early detection.
- Discussion of pharmacological (e.g., hydroxychloroquine, IVIG) and interventional (pacemaker implantation) strategies.
Main Results:
- Fetal echocardiography is crucial for diagnosing CHB and assessing cardiac function.
- Maternal hydroxychloroquine prophylaxis shows promise in preventing CHB development or progression.
- Multimodal therapies, including corticosteroids and IVIG, offer options for refractory cases.
- Pacemaker implantation is a viable option for symptomatic neonates.
Conclusions:
- Early and accurate diagnosis of CHB is critical for timely intervention.
- A multidisciplinary approach involving maternal-fetal medicine specialists, pediatric cardiologists, and electrophysiologists is essential.
- Advances in prenatal and postnatal management offer improved prognoses for CHB-affected infants.
Abstract:
Congenital heart block (CHB) is a rare fetal arrhythmia resulting from disruptions in the heart's electrical conduction system, often linked to maternal autoantibodies or congenital heart defects. This article examines the clinical presentation, pathophysiology, and diagnostic strategies of CHB, emphasizing advances in fetal echocardiography, maternal hydroxychloroquine prophylaxis, and multimodal therapies for refractory cases. Management options, including corticosteroids, intravenous immunoglobulin, and pacemaker implantation, are discussed alongside emerging technologies and pacing systems. By integrating current evidence, this article highlights the importance of early diagnosis, multidisciplinary care, and innovative interventions to improve outcomes for affected pregnancies and neonates.
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Conduction System of the Heart
This system relies on the unique properties of nodal and Purkinje cells:...
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis I: Introduction

